CHRIS A. RALLIS - 03 Jun 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role: Director
Signature: /s/ Chris Rallis
Issuer symbol: FENC
Transactions as of: 03 Jun 2025
Net transactions value: +$157,600
Form type: 4
Filing time: 04 Jun 2025, 16:20:10 UTC
Previous filing: 11 Apr 2025
Next filing: 07 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
RALLIS CHRIS A	Director	C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK	/s/ Chris Rallis	04 Jun 2025	0001185945

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Stock Option	Award	$157,600	+20,000	+11%	$7.88	200,533	03 Jun 2025	Common shares	20,000	$7.88	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 3, 2025, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
F2	The option is 100% vested on date of grant.